| Drug Type Small molecule drug | 
| Synonyms Equagesic, MEPRO-ASPIRIN, Micrainin + [1] | 
| Target | 
| Action inhibitors, agonists | 
| Mechanism COX inhibitors(Cyclooxygenases inhibitors), GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists) | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhaseWithdrawn | 
| First Approval Date United States (15 Apr 1960),  | 
| Regulation- | 
| Molecular FormulaC9H8O4 | 
| InChIKeyBSYNRYMUTXBXSQ-UHFFFAOYSA-N | 
| CAS Registry50-78-2 | 
| KEGG | Wiki | ATC | Drug Bank | 
|---|---|---|---|
| - | Aspirin/Meprobamate | - | 





